Skip to content

Viscoderm

by IBSA FARMACEUTICI ITALIA srl 7 variants

Ref 8033638950531

Active European Union

CE MDR

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 24 Oct 2026. What this means

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number803363895IDK0027A Basic UDI-DI 08033638950531UDI-DIDate9 Sep 2026RegisteredStatusActive

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
Hyaluronic acid sodium salt for intradermal use
Model / Reference
8033638950531
Primary DI / UDI-DI
08033638950531
Basic UDI-DI
803363895IDK0027A
EMDN Code
P900402 Resorbable filling and reconstruction devices
Device Class
Class III
Medical Purpose
BRANDNAME® is indicated for adults of both sexes and intervenes in the restoration of the normal physiological condition of the dermis, in case of xerodermia, related to dermatitis and/or psoriasis. The xerodermia is a physiological state of the skin, characterized by dry skin due to an increase in cell turnover of the stratum corneum. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining such hyaluronic acid at adequate levels in the skin tissues, allow rehydrating the tissues and creating the optimal conditions to prevent and combat the process physically of dry skin, favouring tissue remodelling. Intradermal administration of BRANDNAME® hence allows restoring the physiological quantity of HA in the treated tissues obtaining an benefit for the skin.

Manufacturer details

EUDAMED SRN
IT-PR-000050852

Other devices from IBSA Farmaceutici Italia Srl

See all devices from IBSA Farmaceutici Italia Srl →

Properties

  • Sterile